Close

Kamada (KMDA) Enters Recombinant Human Alpha 1 Antitrypsin Development Agreement

November 15, 2016 7:07 AM EST Send to a Friend
Kamada Ltd. (Nasdaq: KMDA) announced that it has signed a collaboration agreement with Yissum Research Development Company of the Hebrew ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login